Clinical data | |
---|---|
Other names | 5-Ethyl-5-phenylhydantoin |
Routes of administration | By mouth [1] |
ATC code |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
CompTox Dashboard ( EPA) | |
ECHA InfoCard | 100.010.138 |
Chemical and physical data | |
Formula | C11H12N2O2 |
Molar mass | 204.229 g·mol−1 |
3D model ( JSmol) | |
| |
|
Nirvanol, also known as ethylphenylhydantoin, is a derivative of hydantoin with anticonvulsant properties. Its 5-ethyl-5-phenyl substitution pattern is similar to that of phenobarbital. [2] It is useful in the treatment of chorea. [3]
Metabolism of nirvanol is stereoselective, with the (S)- enantiomer undergoing roughly 14 times more hydroxylation at the 4 position of the phenyl group than the (R)-enantiomer. [4] [5]
Clinical data | |
---|---|
Other names | 5-Ethyl-5-phenylhydantoin |
Routes of administration | By mouth [1] |
ATC code |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
CompTox Dashboard ( EPA) | |
ECHA InfoCard | 100.010.138 |
Chemical and physical data | |
Formula | C11H12N2O2 |
Molar mass | 204.229 g·mol−1 |
3D model ( JSmol) | |
| |
|
Nirvanol, also known as ethylphenylhydantoin, is a derivative of hydantoin with anticonvulsant properties. Its 5-ethyl-5-phenyl substitution pattern is similar to that of phenobarbital. [2] It is useful in the treatment of chorea. [3]
Metabolism of nirvanol is stereoselective, with the (S)- enantiomer undergoing roughly 14 times more hydroxylation at the 4 position of the phenyl group than the (R)-enantiomer. [4] [5]